X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Asia

Dainippon Sumitomo Pharma’s Chemistry Research Building, Osaka, Japan

Yuvraj_pawp by Yuvraj_pawp
6th September 2014
in Asia, Projects

Dainippon Sumitomo Pharma (DSP) opened a new chemistry research building in Osaka, Japan, in June 2013. The research facility is located within Sumitomo Chemical’s plant at Osaka research centre in Japan.

The facility helps in improving the efficiency of DSP’s operations in research and development, ranging from drug target discovery to applications for manufacturing and marketing approval.

DSP invested about ¥6.4bn ($64m) for the construction of the new building.

Details of DSP’s R&D facility in Osaka

 

“The research facility is located within Sumitomo Chemical’s plant at Osaka research centre in Japan.”

The new building has eight floors above the ground. It has a total building area of 2,463m² and total floor space of 16,322m². It has laboratories meant for drug discovery, process chemistry and analytical research and development. It will enhance DSP to promote efficient research and development, and facilitate the creation of highly innovative drugs for unmet medical needs.

The facility will carry out drug research on the central nervous system (CNS) as a focus therapeutic area, and cancer and immune-related diseases as challenge therapeutic areas.

The new building will combine the work of the drug discovery division and the technology research and development division. The work in these two divisions is distributed to Osaka research centre in Osaka, and central research laboratories in Suita City.

The research building will optimise chemistry research-related departments assigned to drug discovery research. DSP will be able to focus on improving the efficiency of the series of operations in research and development of drug target discovery and quality management of investigational new drugs through the facility.

Facilities at Dainippon Sumitomo Pharma’s research building

 

The new facility of Dainippon Sumitomo Pharma has meeting spaces located on each floor, which enables active communication for the creative research environment for developing highly originated drugs. It is also equipped with video conference rooms for carrying out communication with other research sites worldwide. It also features a stringent security system for chemical reagent storage.

Construction of the Osaka-based pharma building

 

Ground was broken for the new chemistry research building’s construction in January 2012. The construction was completed in June 2013. The operations are scheduled to begin in July 2013.

The 40m tall building was constructed with a seismic isolation structure to withstand damage caused by earthquakes and liquefaction. It was constructed using foundation improvement methods.

Drugs developed by Japan’s DSP

 

The key drug products developed and produced by Dainippon Sumitomo Pharma include ephedrine indicated for the treatment of bronchial asthma, Gasmotin, a gastroprokinetic agent and Lonasen, which is used for the treatment of schizophrenia. The new Osaka research facility will further help boosting pharmaceutical research of DSP.

Sustainability of the chemistry research facility

 

The building was constructed in compliance with environment-friendly methods. It features airflow fume hoods and is installed with solar panels and energy efficient air conditioning and lighting systems. The building is designed to make the best use of natural light.

Marketing commentary for the Japanese company

 

Dainippon Sumitomo Pharma is a leading international pharmaceuticals company with its head offices located in Osaka and Tokyo, Japan.

“Dainippon Sumitomo Pharma is a leading international pharmaceuticals company.”

The company is engaged in the production, sales and import and export of pharmaceuticals, food additives, veterinary products, diagnostic agents and research materials.

It has more than 7,218 employees with two distribution centres and four manufacturing plants located in Japan.

Its subsidiaries include Sunovion Pharmaceuticals, Boston Biomedical and Sunovion Pharmaceuticals Europe.

Related content

Shionogi Pharmaceutical Research Facility, Osaka, Japan

Shionogi & Co’s new pharmaceutical research facility is located in Toyonaka City in Osaka, Japan.

Sumitomo Pharmaceutical Manufacturing Plant, Japan

 

Sumitomo Pharmaceutical Company (now known as Dainippon Sumitomo Pharma) completed the construction of its manufacturing plant in Ibaraki city, near Osaka in Japan in 2000.

Tags: Asia PacificJapan
Previous Post

Cetilistat - Investigational Drug for Obesity, Japan

Next Post

Aventis Enoxaparin Sodium Manufacturing Plant, Singapore

Related Posts

Indian Pharmaceutical Industry In 2021 And The Road Ahead
Asia

Indian Pharmaceutical Industry In 2021 And The Road Ahead

24th January 2022
Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison
Asia

India crosses historic one billion COVID-19 vaccine milestone

26th October 2021
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
Asia

UAE approves use of Sinopharm vaccine for children aged between 3 and 17 years

5th August 2021
Dr. Reddy’s Laboratories Announces Launch of the Sputnik V vaccine in the Indian Market
Asia

Dr. Reddy’s Laboratories Announces Launch of the Sputnik V vaccine in the Indian Market

17th May 2021
India authorises DRDO's oxygen dependence-lowering drug for Covid-19
Asia

India authorises DRDO’s oxygen dependence-lowering drug for Covid-19

11th May 2021
New dates for MEDICAL FAIR THAILAND with move to 2022
Asia

New dates for MEDICAL FAIR THAILAND with move to 2022

30th April 2021
Next Post

Aventis Enoxaparin Sodium Manufacturing Plant, Singapore

Latest News

FDA Approvals

NHS Acquires Potentially Lifesaving Breast Cancer Medication

9th November 2022
Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In